Specialized proresolving mediators (SPMs) inhibit human B‐cell IgE production
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Specialized proresolving mediators (SPMs) constitute a recently recognized class of bioactive molecules thatpromote the resolution of inflammation. We recently reported that the SPMs resolvin D1 (RvD1) and 17‐hydroxydocosahexaenoic acid (17‐HDHA) promote the differentiation of IgG‐secreting B cells and enhance antibody‐mediated immune responses. However, there is an important knowledge gap regarding whether or not SPMs regulate human B‐cell IgE production, which is the key effector in diseases such as asthma and allergy. Therefore, we investigated whether a panel of diverse SPMs influences B‐cell IgE production. An important finding was that 17‐HDHA and RvD1 inhibit IgE production by human B cells and suppress the differentiation of naïve B cells into IgE‐secreting cells by specifically blocking epsilon germline transcript. This effect is specific to human IgE, as the SPMs do not inhibit production of IgM and IgG and did not suppress other IL‐4‐upregulated genes. 17‐HDHA and RvD1 act by stabilizing the transcriptional repressor B‐cell lymphoma 6, which competes with STAT6 for binding at the epsilon germline transcript promoter. Overall, these new findings demonstrate that certain SPMs inhibit the differentiation of IgE‐producing B cells, without being broadly immune suppressive, representing a novel class of potential therapeutics for IgE‐driven diseases such as asthma and allergy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908
Diversity and dialogue in immunity to helminths
Allen, J. E., & Maizels, R. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri2992 · Cited by 831
The who, where, and when of IgE in allergic airway disease
Dullaers, M., De Bruyne, R., Ramadani, F., Gould, H. J., Gevaert, P., & Lambrecht, B. N. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.029 · Cited by 194
Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells
Ramon, S., Gao, F., Serhan, C. N., & Phipps, R. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103483 · Cited by 145
Self-citationRyan, E. P., Pollack, S. J., Murant, T. I., Bernstein, S. H., Felgar, R. E., & Phipps, R. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2619 · Cited by 101
Self-citation
Cited by
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
“Also, SPMs target B cell epsilon germline transcript to selectively inhibit IgE without decreasing IgM and IgG or IgA production (107).”
BackgroundBioactive Lipids and Chronic Inflammation: Managing the Fire Within
Chiurchiù, V., Leuti, A., & Maccarrone, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00038 · Cited by 427
“Indeed, although only RvD1 has been shown to act on B cells by inducing differentiation into plasma cells and promoting IgM and IgG antibody isotype switching (39) while inhibiting IgE production (40), a growing number of studies are now reporting direct or indirect effects of several SPMs on T cells.”
BackgroundEmerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies
Singh, N. K., & Rao, G. N. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.11.001 · Cited by 345
Kim, N., Lannan, K. L., Thatcher, T. H., Pollock, S. J., Woeller, C. F., & Phipps, R. P. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700503 · Cited by 42
“We recently reported that the SPMs 17-HDHA and RvD1 selectively inhibit IgE production by limiting STAT6 occupancy on the ε germline transcript promoter, which is required for IgE class switch (39).”
BackgroundSelf-citation
Metadata
- Authors
- Kim, N., Ramon, S., Thatcher, T. H., Woeller, C. F., Sime, P. J., & Phipps, R. P.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2015-11-02
- Volume
- 46
- Issue
- 1
- Pages
- 81-91
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1935610350
- Cited by
- 59
- References
- 7
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.